\u201cWe have made the first ever measurements of aluminium in brain tissue from 12 donors diagnosed with\u2026Alzheimer\u2019s disease. The concentrations of aluminium were extremely high, for example, there were values in excess of 10 \u03bcg\/g tissue dry wt. in 5 of the 12 individuals. Overall, the concentrations were higher than all previous measurements of brain aluminium except cases of known aluminium-induced encephalopathy.\u201d \u2013\u00a0<\/em>Dr Christopher Exeley<\/strong><\/p>\nScandalously, for the volunteer patients that were included in the seven separate pre-clinical studies that Merck researchers performed, the researchers did NOT do any questioning of any of the study participants beyond 15 days after each of the series of 3 intramuscular vaccinations had been completed!! Therefore no safety studies beyond the exceedingly short-term were done and thus the \u201cvaccine\/industrial complex\u201d has no justification in insisting that Gardasil is safe!!<\/p>\n
Scandalously, the study participants were actually not questioned, but were simply told to fill out Vaccine Report Cards (VRCs) and send them in at 15 days following the most recent of the 3 injections!!<\/p>\n
Scandalously, 5 of the 7 clinical trials used an aluminum adjuvant \u2013 instead of a saline control \u2013 as a \u201cplacebo\u201d!!<\/p>\n
Scandalously, only one of the 7 studies was properly controlled with a true saline placebo.<\/p>\n
Scandalously, the seventh trial was totally uncontrolled!!<\/p>\n
Scandalously, the seven groups of active vs. \u201cplacebo\u201d were lumped together in the study\u2019s conclusions, which made adequate interpretation of efficacy essentially impossible!!<\/p>\n
Scandalously, the so-called \u201cplacebo\u201d that was used in the vast majority of the trials was the known neurotoxin, Amorphous Aluminum Hydroxyphosphate Sulfate (AAHS), which was the very same adjuvant that was \u2013 and still is \u2013 in the active Gardasil shot!!<\/p>\n
Scandalously, aluminum-containing AAHS, the highly neurotoxic and autoimmunity-inducing adjuvant, is in many other childhood and adult vaccines and is known to accumulate in the body with each injection!!<\/p>\n
Scandalously, no mention was made by Merck that aluminum was in the so-called \u201cplacebo\u201d shots until page 12 of the 28-page product information insert \u2013 and the amount of aluminum was only mentioned once!!<\/p>\n
Scandalously, the participants that did not complete the entire series of 3 vaccinations were dropped from the final tabulations, meaning that those who died or had any of the most serious adverse outcomes (the reason for dropping out) were not included in the final statistics, deceptively minimizing negative outcomes!!<\/p>\n
Scandalously, any trial drop-outs that died, had a stroke, developed seizure disorders, had a heart attack or had other serious adverse outcomes such as one of the many autoimmune disorders were not listed in the literature or product inserts if the victim did not receive all three shots!!<\/p>\n
The following information is taken directly from Merck\u2019s Gardasil product insert that accompanies each vial of vaccine and is to be made available to prospective patients before they give their consent:<\/p>\n
The High Incidence of Headaches Following the Gardasil Vaccine Experiment is Likely Due to the Aluminum Adjuvant<\/strong><\/p>\nThe incidence of new-onset headaches in this healthy, previously headache-free population, for example, was the most commonly-reported systemic adverse reaction \u2013 with an incidence of 28% in both active and \u201cplacebo\u201d treatment groups!!<\/p>\n
(Note that Gardasil recipients experienced an incidence of > 28.2% and the aluminum-adjuvanted [AAHS] \u201cplacebo controls\u201d had a headache incidence of > 28.4%!!)<\/p>\n
This high incidence of serious headaches was highly likely a sign of cerebral vasculitis, which could then cause many of the other adverse effects commonly seen in these previously well patients including chronic fatigue syndrome, seizure disorders, narcolepsy, psychological illnesses or death!!<\/p>\n
Among the causes of death listed in the product insert from 2010, there was printed the following Gardasil-associated deaths among the scrupulously-screened, exceptionally healthy study participants that completed the series of 3 shots: 2 deaths from\u00a0sepsis<\/strong>,<\/p>\n1 death from\u00a0pancreatic cancer<\/strong>,<\/p>\n1\u00a0fatal arrhythmia<\/strong>,<\/p>\n1 death from\u00a0pulmonary tuberculosis<\/strong>, 1 death from\u00a0hyperthyroidism<\/strong>,<\/p>\n1 death from\u00a0post-operative pulmonary embolism<\/strong>\u00a0and\u00a0acute renal failure<\/strong>,<\/p>\n1 death from\u00a0cardiac arrest<\/strong>\u00a0and resultant\u00a0traumatic brain injury<\/strong>, 1 death from\u00a0systemic lupus erythematosus<\/strong>,<\/p>\n1 death because of a\u00a0stroke<\/strong>,<\/p>\n1 death from\u00a0breast cancer<\/strong>, and 1 death from\u00a0nasopharyngeal cancer<\/strong>.<\/p>\nIn the AAHS\/aluminum adjuvant-containing, alleged \u201cplacebo\u201d group there was reported: 1 death from\u00a0\u201casphyxia\u201d,<\/strong><\/p>\n1 death from\u00a0acute lymphocytic leukemia<\/strong>,<\/p>\n1 death from\u00a0\u201cchemical poisoning\u201d<\/strong>\u00a0and<\/p>\n1 death from\u00a0myocardial infarction<\/strong>.<\/p>\nSignificantly,\u00a0zero deaths<\/strong>\u00a0occurred in the true saline placebo group.<\/p>\nFully-informed Consent to Potentially-Risky Medical Treatments Used to be a Part of Medical Ethics<\/strong><\/p>\nThe following Patient Counseling Information comes from the FDA-approved, Merck-generated 2010 Product Information Insert that licensed health practitioners (or the individuals delegated by them to inject the Gardasil) were advised to inform prospective vaccinees (or their parents or guardians) prior to proceeding with the potentially-dangerous, possibly even less-than-useless Gardasil vaccination protocol. (No Gardasil recipient has yet lived long enough to know if the vaccine will have actually prevented cervical cancer!)<\/p>\n
It is highly likely that Merck\u2019s legal advice below is not being followed by the vast majority of America\u2019s medical professionals, whose clinics are profiting heavily by promoting Gardasil vaccinations (HPV vaccines are the most expensive vaccines in the history of the world) for their previously healthy adolescent female patients, who won\u2019t know if it was worth all the shots and costs and risks of chronic illnesses until their reach their mid-40s \u2013 the peak age at which the diagnosis of cancer of the uterine cervix is made.<\/p>\n
No matter, for patients harmed or killed by ANY vaccine \u2013 whether or not they were warned about adverse effects \u2013 cannot sue vaccine manufacturers, marketers or the vaccine-injecting medical profession for injuries or deaths. Scandalous!!<\/p>\n
Most of the following excerpts are verbatim quotes from the product insert:<\/p>\n
PATIENT COUNSELING INFORMATION for Gardasil Vaccinations<\/strong><\/p>\n1.\u00a0\u00a0\u00a0\u00a0\u00a0Vaccination does not eliminate the necessity for women to continue to undergo recommended cervical cancer screening.<\/em><\/strong><\/p>\n2.\u00a0\u00a0\u00a0\u00a0\u00a0Women who receive GARDASIL should continue to undergo cervical cancer screening per standard of care.<\/em><\/strong><\/p>\n3.\u00a0\u00a0\u00a0\u00a0 Recipients of GARDASIL should not discontinue anal cancer screening if it has been recommended by a health care provider.<\/p>\n
4.\u00a0\u00a0\u00a0\u00a0\u00a0GARDASIL has NOT been demonstrated to provide protection against disease from vaccine and non-vaccine HPV types<\/em><\/strong>\u00a0to which a person has previously been exposed through sexual activity.<\/p>\n5.\u00a0\u00a0\u00a0\u00a0\u00a0Since syncope (fainting) has been reported following vaccination sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended.<\/em><\/strong><\/p>\n6.\u00a0\u00a0\u00a0\u00a0\u00a0Vaccine information is required to be given with each vaccination to the patient, parent, or guardian.<\/em><\/strong><\/p>\n7.\u00a0\u00a0\u00a0\u00a0 Information regarding benefits and risks associated with vaccination.<\/p>\n
8.\u00a0\u00a0\u00a0\u00a0 GARDASIL is not recommended for use in pregnant women.<\/p>\n
9.\u00a0\u00a0\u00a0\u00a0 Importance of completing the immunization series unless contraindicated.<\/p>\n
10.\u00a0\u00a0Report any adverse reactions to their health care provider<\/em><\/strong><\/p>\nThe remainder of this article contains information that was obtained directly from the Gardasil package insert (and sometimes paraphrased from what was printed there). I have also bolded, enlarged and\/or italicized some of the words or phrases to point out and\/or emphasize the not-so-subtle, frequent obfuscation of data that the FDA allowed Merck to publish, data which likely was designed to distort (or at least put a positive spin on) the information \u2013 for both patients and physicians: \u00a0\u00a05.1 Syncope\u00a0<\/strong>Because vaccinees may develop syncope (fainting shortly after a Gardasil shot), sometimes resulting in injury, observation for 15 minutes after administration is recommended. Syncope, sometimes associated with\u00a0tonic-clonic movements and other<\/em><\/strong>\u00a0seizure-like<\/strong><\/em>\u00a0activity, has been reported following vaccination with GARDASIL \u00a0 When syncope is associated with tonic-clonic movements\u00a0(tonic\/clonic movements ARE SEIZURES!!),<\/em><\/strong>\u00a0the activity is\u00a0usually<\/em><\/strong>\u00a0transient and\u00a0typically<\/em><\/strong>\u00a0responds to restoring cerebral perfusion by maintaining a supine or Trendelenburg position.<\/p>\nSome vaccine victims died, some had strokes, some had heart attacks, some developed chronic epilepsy, some developed chronic fatigue syndrome, etc.<\/em><\/strong><\/p>\nTable 5: Common Systemic Adverse Reactions in Girls and Women 9 Through 26 Years of Age<\/strong><\/p>\n(GARDASIL \u2265 Control) Adverse Reactions (1 to 15 Days Postvaccination<\/em><\/strong>) GARDASIL (N = 5088) AAHS\/aluminum adjuvant \u201cplacebo\u201d (N = 3790)<\/p>\nFever 13%<\/strong>\u00a0with Gardasil; 11.2% with AAHS\/Aluminum adjuvant \u201cplacebo\u201d,\u00a0Nausea 6.7%<\/strong>\u00a0Gardasil; 6.5% Aluminum,\u00a0Dizziness 4.0%<\/strong>\u00a0Gardasil; 3.6% Aluminum\u00a0Diarrhea 3.6%<\/strong>\u00a0Gardasil; 3.5% Aluminum\u00a0Vomiting 2.4%<\/strong>\u00a0Gardasil; 1.9% Aluminum\u00a0Cough 2.0%<\/strong>\u00a0Gardasil; 1.5% Aluminum\u00a0Toothache, Upper respiratory tract infection, Malaise, Arthralgia, Insomnia, Nasal congestion all had an incidence over 1.0%.<\/strong>\u00a0Many other adverse effects that had an incidence of less than 1.0% were not listed.<\/p>\n6.1 Clinical Trials Experience\u00a0<\/strong>Studies in Girls and Women (ages 9 Through 45) and Boys and Men (9 Through 26 Years of Age)\u00a0<\/strong>18,083 individuals were administered GARDASIL or aluminum\/AAHS \u201cplacebo\u201d or saline placebo on the day of enrollment, and approximately 2 and 6 months thereafter, and safety was evaluated using Vaccination Report Cards (VRC) for 14 days after each injection. \u00a0 The individuals that were monitored using the Vaccination Report Cards included 10,088 individuals 9 through 45 years of age at enrollment who received GARDASIL and 7,995 individuals who received the aluminum \u201cplacebo\u201d or the saline true placebo.<\/p>\n99.8% of trial participants continued to the end of the 6-month trial despite many of them suffering significant adverse effects from both the vaccine and the aluminum adjuvant.<\/p>\n
Table 9:<\/strong>\u00a0Summary of Girls and Women 9 Through 26 Years of Age<\/strong>\u00a0Who Reported an Incident Condition Potentially Indicative of a Systemic Autoimmune Disorder After Enrollment in Clinical Trials\u00a0<\/strong>\u00a0\u00a0(Recall that Aluminum adjuvants have a long history of causing autoimmune disorders.\u00a0<\/em><\/strong>\u00a0<\/em><\/strong>\u00a0It should be required for everybody to read and understand the extensive scholarly literature that had led to the identification of the ASIA Syndrome = \u201cAutoimmune\/Inflammatory Syndrome Induced by Adjuvants\u201d at:<\/em><\/strong>\u00a0https:\/\/autoimmunity-network.com\/media\/moxie\/files\/a\/ad\/adm\/admin\/The%20autoimmune-inflammatory%20syndrome%20induced%20by%20adjuvants.pdf<\/a>\u00a0\u00a0 Note: Patients with the vaccine-induced ASIA Syndrome commonly present with post-vaccination symptoms such as\u00a0chronic fatigue syndrome, cognitive impairment, arthralgias, myalgias,\u00a0fevers, dry eyes and dry mouth, symptoms that are totally compatible with the ASIA Syndrome and are now found to occur following Gardasil vaccinations. Included are some of these disorders:<\/em><\/strong>\u00a0\u00a0<\/em><\/strong><\/p>\n1.\u00a0\u00a0\u00a0\u00a0\u00a0<\/em><\/strong>Arthralgia\/Arthritis\/Arthropathy\u00a0<\/em><\/strong>\u00a0\u00a0120 Gardasil-injected volunteers reported arthropathic signs and symptoms that were compatible with autoimmune arthropathies (and the ASIA Syndrome).<\/em><\/strong>\u00a0\u00a0<\/em><\/strong>\u00a098 aluminum-adjuvanted \u201ccontrol group\u201d members also reported arthropathies.<\/em><\/strong><\/p>\n2.\u00a0\u00a0\u00a0\u00a0\u00a0<\/em><\/strong>There were\u00a010 cases of Insulin Dependent Diabetes Mellitus<\/em><\/strong>\u00a0(a known autoimmune disorder) in the Gardasil group and there were\u00a06 cases of IDDM<\/em><\/strong>\u00a0among the\u00a0aluminum-adjuvant group.<\/em><\/strong><\/p>\n3.\u00a0\u00a0\u00a0\u00a0\u00a0<\/em><\/strong>Also occurring among these previously totally healthy groups of young women were cases of these\u00a0autoimmune, ASIA disorders<\/strong>:\u00a0\u00a0<\/em><\/strong>\u00a0Autoimmune Thyroiditis,\u00a0<\/em><\/strong>Celiac Disease,\u00a0<\/em><\/strong>